AGENT FOR ENHANCING PHAGOCYTOSIS ABILITY OF NEUTROPHILS

This technology relates to an agent for enhancing phagocytosis ability of neutrophils, and more particularly, to an agent for enhancing phagocytosis ability of neutrophils including a histidine-rich glycoprotein as an active ingredient.

This technology relates to an agent for enhancing the phagocytosis ability of neutrophils, and more particularly, to an agent for enhancing the phagocytosis ability of neutrophils including a histidine-rich glycoprotein as an active ingredient.

Abstract

This technology provides an agent for enhancing phagocytosis ability, specifically an agent for enhancing phagocytosis ability that functions as a therapeutic agent or therapeutic adjunct for various bacterial infectious diseases, viral infectious diseases, fungal infectious diseases, parasitic infectious diseases, and mixed infectious diseases thereof by enhancing phagocytosis ability of neutrophils. The above-mentioned object is achieved by an agent for enhancing phagocytosis ability including HRG as an active ingredient. The inventors of the present invention have focused attention on the function of HRG on the regulation of neutrophil activities, and as the result of extensive investigations, have newly found that HRG effectively enhances phagocytosis ability against a pathogen or foreign matter derived from bacteria, viruses, fungi, parasites, and the like among the neutrophil activities.

Website

http://www.okayama-u.ac.jp/index_e.html